ReviewCurrent epidemiology reports2026
Diabetic Cardiovascular Complications in Women and Young Adults.
Review in Current epidemiology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of Review: Cardiovascular disease (CVD) is the major complication and leading cause of death among individuals with type 2 diabetes (T2D). Women and younger adults with T2D face a disproportionately higher risk of CVD, compared with their male or older counterparts. This review summarizes clinical and epidemiological evidence on the mechanisms underlying these disparities and highlights directions for future research and clinical practice. Recent Findings: Women with T2D lose the cardioprotection typically seen in the general population and face disproportionately higher cardiovascular risk. This excess risk is influenced by adverse metabolic profiles preceding T2D onset; female-specific factors such as polycystic ovary syndrome and gestational complications; and non-biological contributors, including delayed diagnosis and less optimal healthcare utilization and delivery in women compared with men. Young adults with early-onset T2D also experience a heightened cardiovascular burden, driven by a more aggressive disease course, prolonged exposure to metabolic abnormalities, and distinctive psychosocial stressors that compound their risk. Despite these disparities, both female and young adult patients with T2D remain understudied, hindering the development of precision prevention and management strategies. Summary: Future mechanistic and interventional research that integrates sex and age as key biological factors will be critical for advancing precision approaches and reducing disparities in diabetes care and outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.